ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Black Hole Quencher-Enhanced Plasmonic Photothermal Conversion.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A common goal in the field of thermoplasmonics is to improve the photothermal conversion efficiency (PCE) of plasmonic nanostructures, yet it is highly challenging. We herein report a universal method to dramatically improve plasmonic photothermal conversion by add-on black hole quencher (BHQ) molecules. BHQs, nonfluorescent resonant molecules, are immobilized to matched metal nanostructures to afford the excited coupling plasmonic hybrids with charge/energy transfer upon laser irradiation. Photothermal efficacy test confirms that the PCE of the hybrids is much higher than that of the sum of single plasmon and BHQ alone, leading to enhanced plasmonic photothermal conversion by approximately three times. Moreover, the PCE of the hybrid nanoparticles exhibits a nonlinear response to the plasmon fields, a phenomenon that cannot be achieved by fluorophores. The comparative experiments suggest that the whole photothermal efficacy of this hybrid stems from plasmonic nanoparticles, BHQ itself, as well as the mutual charge/energy transfer interaction. We demonstrate the generalizability of the strategy on various plasmonic nanostructures with three absorption-matched BHQs. The resultant BHQ-plasmon hybrids with enhanced conversion as high as 69.1% in NIR-II, which allows for highly efficient hyperthermia ablation of cancer cells in vitro and deep-seated tumors in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.